Jack Nathan Medical AI Stock Analysis
Jack Nathan Medical (JNHMF) AI Stock Analysis
Jack Nathan Medical
(Other OTC:JNHMF)
No summary available
Jack Nathan Medical (JNHMF) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $87.10K
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -0.1
- Beta (1Y)
- 11.69
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- US
- Employees
- 24
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Jack Nathan Medical Business Overview & Revenue Model
Company Description
Jack Nathan Medical Corp. (JNH.V), along with its affiliated entities, primarily delivers primary healthcare services under the Jack Nathan Health brand. These medical clinics are predominantly located within Walmart Supercentres. As of June 30, 2022...
Jack Nathan Medical Peers Comparison
Overall Rating
TSE:NLH72Outperform
TSE:CRRX63Neutral
TSE:WELL48Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | CAD 42.78M | 24.53 | 6.40% | ― | 15.57% | 65.83% | |
| 63Neutral | CAD 203.53M | 7.89 | 23.35% | 2.55% | 3.42% | 40560.00% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 48Neutral | CAD 982.84M | -7.82 | -15.34% | ― | 29.14% | -189.23% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JNHMF | Jack Nathan Medical Corp | 0.02 | 0.00 | 0.00% | |
| TSE:CRRX | Carerx Corporation | 3.22 | -0.18 | -5.27% | |
| TSE:NLH | Nova Leap Health | 0.49 | 0.19 | 63.33% | |
| TSE:WELL | Well Health Technologies | 3.84 | -0.10 | -2.54% | |
| TSE:CALM | Revitalist Lifestyle & Wellness Ltd. | 0.02 | 0.00 | 0.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
